In the first 2 of a series of 6 new guidelines to be released this year, the American Academy of Dermatology and National Psoriasis Foundation address biologic use and comorbidities in the treatment of psoriasis.

News

News
Monday, March 19, 2018
Researchers recently investigated the safety and efficacy of treatment with an interleukin 17A antagonist among patients with psoriatic arthritis.
News
Monday, March 12, 2018
Patients with psoriasis have an increased risk for cardiovascular events. In a recent study, researchers compared the effects of treatment with tumor necrosis factor-alpha inhibitors or phototherapy on this risk.
News
Tuesday, February 20, 2018
The results of a recent study have indicated potential gaps in the treatment of various cardiovascular risk factors in patients with psoriatic disease.
News
Wednesday, February 14, 2018
Researchers compared the efficacy of 8 immunomodulators at improving skin among patients with moderate to severe plaque psoriasis in a recent study.

NPF Endorsed Articles

NPF Endorsed Articles
Friday, September 19, 2014
This article, based on a presentation that was given at the Interdisciplinary Autoimmune Summit held in June 2014 in Las Vegas, describes how to select the right biologic for a patient who has not previously received biologic therapy.   
NPF Endorsed Articles
Thursday, August 21, 2014
The interleukin-17A inhibitor secukinumab was effective in the treatment of psoriasis, according to 2 large studies. 
NPF Endorsed Articles
Tuesday, July 22, 2014
The link between psoriasis and other medical conditions such as psoriatic arthritis (PsA), cardiovascular disease, metabolic disorder, inflammatory bowel disease, psychiatric disorders, lymphoma and ocular disease is being recognized by a growing body of peer review literature. 

Research in Review

Research in Review
Wednesday, May 11, 2016
Make sure you do not mistake signs of psoriasis in patients of color.
Research in Review
Tuesday, April 19, 2016
Posters presented at The Winter Clinical Dermatology Conference-Hawaii look at treatment options for psoriasis.
Research in Review
Monday, March 28, 2016
Gary Goldenberg, MD, discusses the latest oral agents for individuals living with psoriasis.